UNIC Technology Corp. (5452.TWO)
New Taipei City, TW
UNIC Technology Corp., established in 1991 and headquartered in New Taipei City, Taiwan, specializes in the trading of plastic materials. The company's diverse product portfolio features bio-based and conventional plastic materials, alongside advanced rapid self-heating and cooling mold tooling solutions. These offerings are vital for a broad spectrum of applications, including consumer electronics such as LCD televisions, monitors, mobile phones, chargers, adapters, connectors, notebook computers, and office automation equipment. They also serve household appliances, backlight units, motor components, and various molded products like bottles, films, and food packaging. Furthermore, UNIC Technology Corp. distributes environmentally friendly materials, engineering plastics, electronic components, and automotive parts.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +8.04% | -1.41% | +11.13% | +0.58% | +60.32% | +23.94% | +25.27% | +70.90% | +28.26% | +192.47% | +164.37% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals - Specialty: +4.7%-14.0% Q1'26: -18.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-17.5% Q1'26: -92.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.9% ★ Q1'26: -8.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+2.7% Q1'26: +0.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+3.4% Q1'26: +0.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+24.3% Q1'26: -165.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×5.21× ★ Q1'26: 12.61× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | B- | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | B- | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | B- | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | B- | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | B- | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | B- | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | B- | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.01% | 9.9K | 0.42% |
| 2 | Avantis Emerging Markets Value ETF AVES | 0.00% | 72.5K | 0.36% |
| 3 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 13.9K | 0.44% |
| 4 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 430.3K | 0.33% |
| 5 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 114.2K | 0.39% |
| 6 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 20.9K | 0.46% |
| 7 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.00% | 1.9K | 0.35% |
| 8 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 62.5K | 0.29% |
| 9 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 48.5K | 0.28% |
| 10 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.00% | 993.71 | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Erin Huang | Head of Internal Control | — | — |
| Riwang Lin | GM & Director | — | — |
| Shuling Yang | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 5452.TWO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
